Exemestane: Difference between revisions
(CSV import) |
(CSV import) |
||
| Line 1: | Line 1: | ||
{{Definitions | {{Definitions | ||
|Term=Exemestane | |Term=Exemestane | ||
|Short definition= | |Short definition=Exemestane (EK-seh-MEH-stay) A drug used to treat postmenopausal women with advanced or early-stage breast cancer that is estrogen receptor positive (ER+). It is used in patients whose cancer has already been treated with tamoxifen. | ||
|Type=Cancer terms | |Type=Cancer terms | ||
|Specialty=Oncology | |Specialty=Oncology | ||
Latest revision as of 15:22, 11 January 2023
| Exemestane | |
|---|---|
| Term | Exemestane |
| Short definition | Exemestane (EK-seh-MEH-stay) A drug used to treat postmenopausal women with advanced or early-stage breast cancer that is estrogen receptor positive (ER+). It is used in patients whose cancer has already been treated with tamoxifen. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Exemestane - (pronounced) (EK-seh-MEH-stay) A drug used to treat postmenopausal women with advanced or early-stage breast cancer that is estrogen receptor positive (ER+). It is used in patients whose cancer has already been treated with tamoxifen. It is also being studied in the treatment of other types of cancer. Exemestane lowers the amount of estrogen produced by the body. This can stop the growth of cancer cells that need estrogen to grow. Exemestane is a type of aromatase inhibitor. Also called aromasin
External links
- Medical encyclopedia article on Exemestane
- Wikipedia's article - Exemestane
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski